Business
Transforming Health: LumiraDx, AstraZeneca, and Everton FC’s Visionary Partnership
In a historic development, small-cap medical technology firm LumiraDx Ltd (NASDAQ:LMDX) experienced an unprecedented surge of 174% during early trading on Monday, propelled by a...
Creative Realities Projects Strong Revenue Growth, Exceeds Analyst Expectations
Creative Realities, a leading force in digital signage and media solutions, has unveiled projections indicating a substantial boost in revenue for the second half of...
Comerica Anticipates Decline in Net Interest Income Amidst High Interest Rates
Comerica, headquartered in Texas, announced on Friday that it expects a decline in its net interest income (NII) for the current quarter, reflecting challenges faced...
GM, Ford, Stellantis Propose 30% Wage Increase Amid Ongoing Auto Worker Strike
In a significant shift, General Motors (GM), Ford, and Stellantis extended an olive branch to over 34,000 striking auto workers on Friday, presenting an offer...
Volkswagen Lowers 2023 Profit Margin Outlook Due to Raw Material Challenges
Europe’s leading automaker, Volkswagen announced on Friday a downward revision of its profit margin forecast for 2023, citing adverse impacts stemming from raw material hedges...
American Express Surpasses Expectations with Q3 Profits
Credit card powerhouse American Express unveiled third-quarter (Q3) profits on Friday that outperformed projections, bolstered by unwavering expenditure from its affluent clientele. Despite mounting concerns...
Mixed Earnings Fail to Boost Stock Market as Uncertainty Persists
Companies have been reporting robust earnings in the third quarter, surpassing both top and bottom-line expectations. However, these impressive strong earnings have failed to uplift...
SLB Reports Sequential Dip in North American Sales, Expects Growth in International Markets
Schlumberger (SLB), the world’s largest oil-services provider, has recorded its first sequential decline in North American sales since the onset of 2021. This shift comes...
XORTX Therapeutics Inc Witnesses Surge in Stock Price
The stock price of clinical-stage biopharmaceutical firm XORTX Therapeutics Inc (NASDAQ: XRTX) has experienced a notable upswing, despite the absence of substantial news releases. According...
Lipella Pharmaceuticals Sees Surge in Shares Following FDA Approval for Clinical Trial
Shares of Lipella Pharmaceuticals, a clinical-stage biotechnology company (Nasdaq: LIPO), experienced a notable surge on Friday amid robust trading activity, with over 38 million shares...
